Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drug Discovery | 10 | 2013 | 324 | 2.310 |
Why?
|
Drug Design | 11 | 2013 | 375 | 2.080 |
Why?
|
Computer-Aided Design | 4 | 2012 | 73 | 1.260 |
Why?
|
Computational Biology | 9 | 2013 | 1271 | 1.200 |
Why?
|
User-Computer Interface | 4 | 2013 | 286 | 1.110 |
Why?
|
Quantitative Structure-Activity Relationship | 7 | 2012 | 30 | 0.910 |
Why?
|
Proto-Oncogene Proteins c-akt | 7 | 2012 | 2054 | 0.840 |
Why?
|
Proteins | 5 | 2012 | 1963 | 0.820 |
Why?
|
Models, Molecular | 12 | 2013 | 1732 | 0.730 |
Why?
|
Lipid Bilayers | 1 | 2018 | 52 | 0.670 |
Why?
|
Glucuronides | 4 | 2013 | 37 | 0.670 |
Why?
|
Phospholipids | 1 | 2018 | 177 | 0.630 |
Why?
|
Ligands | 6 | 2012 | 995 | 0.630 |
Why?
|
Drug Delivery Systems | 3 | 2012 | 669 | 0.630 |
Why?
|
Databases, Pharmaceutical | 2 | 2013 | 7 | 0.570 |
Why?
|
Polypharmacy | 2 | 2013 | 57 | 0.520 |
Why?
|
Blood Proteins | 3 | 2011 | 294 | 0.520 |
Why?
|
Small Molecule Libraries | 3 | 2013 | 169 | 0.510 |
Why?
|
Drug Interactions | 2 | 2013 | 553 | 0.490 |
Why?
|
Nanoparticles | 1 | 2018 | 554 | 0.480 |
Why?
|
Thiamine Deficiency | 5 | 1997 | 10 | 0.450 |
Why?
|
Models, Chemical | 3 | 2013 | 186 | 0.440 |
Why?
|
Antineoplastic Agents | 12 | 2016 | 14289 | 0.430 |
Why?
|
Structure-Activity Relationship | 7 | 2013 | 931 | 0.430 |
Why?
|
Microsomes, Liver | 1 | 2013 | 115 | 0.430 |
Why?
|
Models, Theoretical | 2 | 2007 | 785 | 0.430 |
Why?
|
Molecular Docking Simulation | 1 | 2012 | 144 | 0.420 |
Why?
|
Ether-A-Go-Go Potassium Channels | 1 | 2011 | 7 | 0.420 |
Why?
|
Prescription Drugs | 1 | 2013 | 64 | 0.420 |
Why?
|
Biological Assay | 1 | 2013 | 177 | 0.410 |
Why?
|
ras Proteins | 1 | 2016 | 770 | 0.400 |
Why?
|
Potassium Channel Blockers | 1 | 2011 | 110 | 0.400 |
Why?
|
Serum Response Factor | 3 | 2007 | 51 | 0.400 |
Why?
|
Phosphoproteins | 3 | 2011 | 1152 | 0.390 |
Why?
|
Glucuronosyltransferase | 4 | 2012 | 104 | 0.380 |
Why?
|
Hepatocytes | 1 | 2013 | 351 | 0.380 |
Why?
|
Protein Binding | 12 | 2012 | 3438 | 0.360 |
Why?
|
Protein Kinase Inhibitors | 6 | 2013 | 4757 | 0.360 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2011 | 226 | 0.360 |
Why?
|
RNA | 2 | 2012 | 1013 | 0.350 |
Why?
|
HIV Protease | 1 | 2008 | 6 | 0.340 |
Why?
|
Binding Sites | 8 | 2012 | 2171 | 0.320 |
Why?
|
Wernicke Encephalopathy | 3 | 1997 | 12 | 0.310 |
Why?
|
High-Throughput Screening Assays | 4 | 2014 | 216 | 0.310 |
Why?
|
Sequence Analysis, Protein | 1 | 2008 | 81 | 0.310 |
Why?
|
Protein Conformation | 8 | 2012 | 1258 | 0.310 |
Why?
|
Drug-Related Side Effects and Adverse Reactions | 1 | 2013 | 598 | 0.310 |
Why?
|
Indolizines | 1 | 2007 | 45 | 0.300 |
Why?
|
Phenanthrenes | 1 | 2007 | 42 | 0.300 |
Why?
|
Alkaloids | 1 | 2007 | 75 | 0.290 |
Why?
|
Models, Biological | 5 | 2013 | 3254 | 0.290 |
Why?
|
Models, Statistical | 2 | 2013 | 1171 | 0.290 |
Why?
|
Database Management Systems | 1 | 2006 | 63 | 0.280 |
Why?
|
Pharmaceutical Preparations | 1 | 2008 | 152 | 0.280 |
Why?
|
Drug Screening Assays, Antitumor | 5 | 2013 | 566 | 0.280 |
Why?
|
Crystallography, X-Ray | 4 | 2012 | 627 | 0.260 |
Why?
|
Computer Simulation | 6 | 2014 | 1529 | 0.260 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2013 | 1756 | 0.260 |
Why?
|
Dimethyl Sulfoxide | 1 | 2005 | 52 | 0.260 |
Why?
|
Protein Structure, Tertiary | 6 | 2011 | 1487 | 0.250 |
Why?
|
Molecular Targeted Therapy | 2 | 2012 | 2330 | 0.230 |
Why?
|
Thermodynamics | 2 | 2012 | 196 | 0.200 |
Why?
|
MicroRNAs | 3 | 2014 | 2947 | 0.200 |
Why?
|
Phenols | 2 | 2012 | 107 | 0.190 |
Why?
|
Myosin Heavy Chains | 1 | 2001 | 128 | 0.190 |
Why?
|
Software | 1 | 2008 | 1321 | 0.190 |
Why?
|
Databases, Factual | 2 | 2007 | 2218 | 0.190 |
Why?
|
Protein Subunits | 2 | 2008 | 274 | 0.180 |
Why?
|
Neoplasms | 5 | 2016 | 15193 | 0.180 |
Why?
|
Thalamus | 3 | 1997 | 132 | 0.170 |
Why?
|
Entropy | 1 | 2018 | 37 | 0.170 |
Why?
|
Static Electricity | 1 | 2018 | 58 | 0.170 |
Why?
|
Poisson Distribution | 1 | 2018 | 91 | 0.170 |
Why?
|
Muscles | 3 | 2005 | 416 | 0.160 |
Why?
|
Kinetics | 5 | 2013 | 2049 | 0.160 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2013 | 503 | 0.160 |
Why?
|
Down-Regulation | 4 | 2014 | 2074 | 0.140 |
Why?
|
Biotransformation | 2 | 2013 | 93 | 0.140 |
Why?
|
Humans | 29 | 2016 | 261506 | 0.140 |
Why?
|
Drosophila | 1 | 2001 | 839 | 0.130 |
Why?
|
Catalysis | 3 | 2013 | 250 | 0.130 |
Why?
|
Diencephalon | 1 | 1995 | 14 | 0.130 |
Why?
|
Animals | 24 | 2014 | 59536 | 0.130 |
Why?
|
Databases, Protein | 2 | 2013 | 100 | 0.120 |
Why?
|
Flavonols | 2 | 2011 | 7 | 0.120 |
Why?
|
Alcoholism | 1 | 1997 | 285 | 0.120 |
Why?
|
Dizocilpine Maleate | 1 | 1993 | 21 | 0.120 |
Why?
|
Flavonoids | 2 | 2012 | 188 | 0.120 |
Why?
|
Cysteine | 2 | 2012 | 214 | 0.120 |
Why?
|
Rhodium | 1 | 2013 | 7 | 0.120 |
Why?
|
S-Phase Kinase-Associated Proteins | 1 | 2013 | 51 | 0.120 |
Why?
|
Oligonucleotides | 1 | 2014 | 227 | 0.120 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 2003 | 72 | 0.110 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2014 | 155 | 0.110 |
Why?
|
Mutant Proteins | 1 | 2014 | 234 | 0.110 |
Why?
|
Caco-2 Cells | 2 | 2012 | 158 | 0.110 |
Why?
|
Serum Albumin, Bovine | 1 | 2013 | 83 | 0.110 |
Why?
|
Cerebral Cortex | 1 | 1997 | 621 | 0.110 |
Why?
|
In Situ Hybridization | 3 | 2005 | 1037 | 0.110 |
Why?
|
Myoblasts, Cardiac | 1 | 2012 | 12 | 0.110 |
Why?
|
Proto-Oncogene Protein c-ets-2 | 1 | 2012 | 22 | 0.110 |
Why?
|
Metabolic Clearance Rate | 1 | 2013 | 231 | 0.110 |
Why?
|
Molecular Conformation | 1 | 2012 | 171 | 0.110 |
Why?
|
Amino Acids | 2 | 2004 | 728 | 0.110 |
Why?
|
Sulfotransferases | 1 | 2012 | 36 | 0.110 |
Why?
|
Flavones | 1 | 2011 | 15 | 0.100 |
Why?
|
Algorithms | 3 | 2012 | 3890 | 0.100 |
Why?
|
Chromones | 1 | 2011 | 120 | 0.100 |
Why?
|
Genes, Reporter | 4 | 2011 | 798 | 0.100 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2011 | 37 | 0.100 |
Why?
|
Cyclohexanones | 1 | 2011 | 30 | 0.100 |
Why?
|
Drug Industry | 1 | 2012 | 88 | 0.100 |
Why?
|
Cell Transdifferentiation | 1 | 2012 | 112 | 0.100 |
Why?
|
Transcription, Genetic | 3 | 2005 | 3154 | 0.100 |
Why?
|
Molecular Dynamics Simulation | 1 | 2012 | 131 | 0.100 |
Why?
|
Sulfonamides | 2 | 2011 | 1823 | 0.100 |
Why?
|
Inhibitory Concentration 50 | 1 | 2011 | 289 | 0.100 |
Why?
|
Protein Interaction Mapping | 1 | 2012 | 162 | 0.100 |
Why?
|
Transcription Factor RelA | 1 | 2011 | 184 | 0.100 |
Why?
|
Molecular Structure | 4 | 2012 | 515 | 0.100 |
Why?
|
Pyridones | 1 | 2013 | 348 | 0.090 |
Why?
|
Homeodomain Proteins | 3 | 2005 | 1143 | 0.090 |
Why?
|
I-kappa B Kinase | 1 | 2011 | 250 | 0.090 |
Why?
|
Gene Expression Regulation | 3 | 2007 | 4053 | 0.090 |
Why?
|
Thiadiazoles | 1 | 2010 | 47 | 0.090 |
Why?
|
Polynucleotide Adenylyltransferase | 1 | 2009 | 10 | 0.090 |
Why?
|
Oncogene Protein v-akt | 1 | 2010 | 101 | 0.090 |
Why?
|
ATP Synthetase Complexes | 1 | 2009 | 5 | 0.090 |
Why?
|
Cell Membrane Permeability | 1 | 2009 | 122 | 0.090 |
Why?
|
2-Chloroadenosine | 1 | 2009 | 37 | 0.090 |
Why?
|
Thiepins | 1 | 2008 | 2 | 0.080 |
Why?
|
Time Factors | 5 | 2012 | 12926 | 0.080 |
Why?
|
Genes, ras | 1 | 2012 | 667 | 0.080 |
Why?
|
Hippocampus | 2 | 1994 | 915 | 0.080 |
Why?
|
Myocardium | 3 | 2005 | 1313 | 0.080 |
Why?
|
Thymidine Kinase | 1 | 2009 | 193 | 0.080 |
Why?
|
Dimerization | 1 | 2008 | 304 | 0.080 |
Why?
|
Lac Operon | 2 | 2005 | 122 | 0.080 |
Why?
|
beta-Galactosidase | 2 | 2005 | 211 | 0.080 |
Why?
|
Protein Structure, Secondary | 1 | 2008 | 336 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2013 | 854 | 0.080 |
Why?
|
Arrhythmias, Cardiac | 1 | 2011 | 473 | 0.080 |
Why?
|
Seizures | 1 | 1993 | 989 | 0.080 |
Why?
|
Cost-Benefit Analysis | 1 | 2012 | 945 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 4 | 1997 | 2063 | 0.080 |
Why?
|
Protein Isoforms | 3 | 2011 | 842 | 0.080 |
Why?
|
Peptide Fragments | 1 | 2003 | 1271 | 0.080 |
Why?
|
Adenosine Triphosphate | 1 | 2009 | 571 | 0.080 |
Why?
|
Adenosine | 1 | 2009 | 289 | 0.070 |
Why?
|
Organogenesis | 1 | 2007 | 119 | 0.070 |
Why?
|
Intestinal Mucosa | 1 | 2013 | 1081 | 0.070 |
Why?
|
Skin | 1 | 2012 | 1259 | 0.070 |
Why?
|
Pyrithiamine | 3 | 1995 | 3 | 0.070 |
Why?
|
Transgenes | 3 | 2005 | 557 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 3639 | 0.070 |
Why?
|
Transcription Factors | 5 | 2014 | 5270 | 0.070 |
Why?
|
Myosins | 1 | 2005 | 96 | 0.070 |
Why?
|
Fibroblasts | 1 | 2012 | 1682 | 0.070 |
Why?
|
Mesoderm | 2 | 2005 | 404 | 0.070 |
Why?
|
Nucleotides | 1 | 2005 | 164 | 0.060 |
Why?
|
Neoplastic Stem Cells | 1 | 2013 | 1443 | 0.060 |
Why?
|
Research Design | 1 | 2012 | 1544 | 0.060 |
Why?
|
Liver | 2 | 2011 | 2961 | 0.060 |
Why?
|
Databases as Topic | 1 | 2005 | 133 | 0.060 |
Why?
|
Nerve Degeneration | 2 | 1997 | 148 | 0.060 |
Why?
|
Mice | 11 | 2014 | 34495 | 0.060 |
Why?
|
Brain | 2 | 1997 | 4113 | 0.060 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 568 | 0.060 |
Why?
|
Genetic Vectors | 2 | 2012 | 1694 | 0.060 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2005 | 161 | 0.060 |
Why?
|
Amino Acid Motifs | 1 | 2005 | 392 | 0.060 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2005 | 611 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 4892 | 0.060 |
Why?
|
Enzyme Inhibitors | 2 | 2009 | 1879 | 0.060 |
Why?
|
Blotting, Western | 2 | 2012 | 3536 | 0.060 |
Why?
|
Luciferases | 1 | 2005 | 445 | 0.060 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2005 | 518 | 0.060 |
Why?
|
Rats | 4 | 1997 | 6086 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2014 | 8873 | 0.060 |
Why?
|
Heart | 2 | 2007 | 1223 | 0.060 |
Why?
|
Adenosine Triphosphatases | 1 | 2005 | 435 | 0.060 |
Why?
|
Enhancer Elements, Genetic | 1 | 2005 | 467 | 0.060 |
Why?
|
Learning | 1 | 2006 | 403 | 0.060 |
Why?
|
Cloning, Molecular | 1 | 2005 | 1213 | 0.050 |
Why?
|
DNA Mutational Analysis | 1 | 2008 | 2283 | 0.050 |
Why?
|
Xenopus Proteins | 1 | 2003 | 185 | 0.050 |
Why?
|
Medical Oncology | 1 | 2011 | 1423 | 0.050 |
Why?
|
Heterozygote | 1 | 2005 | 1020 | 0.050 |
Why?
|
Exons | 2 | 2005 | 1328 | 0.050 |
Why?
|
DNA | 2 | 2011 | 2693 | 0.050 |
Why?
|
Pharyngeal Muscles | 1 | 2001 | 36 | 0.050 |
Why?
|
Recombinant Proteins | 3 | 2012 | 2927 | 0.050 |
Why?
|
Embryonic and Fetal Development | 1 | 2001 | 205 | 0.050 |
Why?
|
Genome | 1 | 2005 | 672 | 0.050 |
Why?
|
Homeobox Protein Nkx-2.5 | 3 | 2005 | 27 | 0.050 |
Why?
|
Mice, Nude | 3 | 2014 | 4307 | 0.050 |
Why?
|
Biomarkers | 1 | 2011 | 5047 | 0.050 |
Why?
|
Transfection | 1 | 2005 | 2944 | 0.040 |
Why?
|
Cell Line, Tumor | 5 | 2014 | 14551 | 0.040 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 622 | 0.040 |
Why?
|
Chromatin | 1 | 2005 | 942 | 0.040 |
Why?
|
Drosophila melanogaster | 1 | 2005 | 829 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2005 | 1498 | 0.040 |
Why?
|
Mutation | 2 | 2012 | 15179 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2005 | 2508 | 0.040 |
Why?
|
Glycolysis | 2 | 2013 | 519 | 0.040 |
Why?
|
Up-Regulation | 1 | 2005 | 2450 | 0.040 |
Why?
|
Oligonucleotides, Antisense | 2 | 2014 | 248 | 0.040 |
Why?
|
Signal Transduction | 3 | 2012 | 11965 | 0.040 |
Why?
|
Alternative Splicing | 1 | 2001 | 584 | 0.040 |
Why?
|
Cell Differentiation | 2 | 2007 | 4078 | 0.040 |
Why?
|
Mammillary Bodies | 1 | 1997 | 3 | 0.040 |
Why?
|
Microdialysis | 2 | 1994 | 50 | 0.040 |
Why?
|
Binding, Competitive | 2 | 2008 | 300 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2005 | 2022 | 0.040 |
Why?
|
Cell Line | 1 | 2005 | 5114 | 0.040 |
Why?
|
Embryo, Mammalian | 3 | 2005 | 741 | 0.040 |
Why?
|
Models, Genetic | 1 | 2001 | 1113 | 0.040 |
Why?
|
Atrophy | 1 | 1997 | 261 | 0.040 |
Why?
|
Cell Count | 1 | 1997 | 508 | 0.030 |
Why?
|
Gyrus Cinguli | 1 | 1997 | 140 | 0.030 |
Why?
|
Nervous System | 1 | 1996 | 165 | 0.030 |
Why?
|
Neural Pathways | 1 | 1997 | 298 | 0.030 |
Why?
|
Sequence Alignment | 2 | 2008 | 844 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2005 | 6150 | 0.030 |
Why?
|
Elongin | 1 | 2014 | 9 | 0.030 |
Why?
|
Mice, SCID | 2 | 2009 | 1869 | 0.030 |
Why?
|
Histamine | 1 | 1994 | 53 | 0.030 |
Why?
|
Chromosomes, Artificial, Bacterial | 2 | 2005 | 129 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 5319 | 0.030 |
Why?
|
Thiamine | 1 | 1993 | 11 | 0.030 |
Why?
|
Male | 6 | 2013 | 123000 | 0.030 |
Why?
|
Cyclization | 1 | 2013 | 21 | 0.030 |
Why?
|
Extracellular Space | 1 | 1993 | 132 | 0.030 |
Why?
|
Circular Dichroism | 1 | 2003 | 113 | 0.030 |
Why?
|
Solutions | 1 | 2003 | 104 | 0.030 |
Why?
|
Brain Mapping | 1 | 1997 | 644 | 0.030 |
Why?
|
United States | 1 | 2010 | 15433 | 0.030 |
Why?
|
Mice, Transgenic | 3 | 2005 | 4143 | 0.030 |
Why?
|
Phloretin | 1 | 2012 | 5 | 0.030 |
Why?
|
Kaempferols | 1 | 2012 | 8 | 0.030 |
Why?
|
Apigenin | 1 | 2012 | 12 | 0.030 |
Why?
|
Flavanones | 1 | 2012 | 11 | 0.030 |
Why?
|
Actins | 2 | 2005 | 608 | 0.030 |
Why?
|
Multienzyme Complexes | 1 | 2013 | 213 | 0.030 |
Why?
|
Arylsulfotransferase | 1 | 2012 | 18 | 0.030 |
Why?
|
Genistein | 1 | 2012 | 73 | 0.030 |
Why?
|
Aspartic Acid | 1 | 2012 | 126 | 0.030 |
Why?
|
Reference Values | 1 | 1993 | 1099 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2012 | 276 | 0.020 |
Why?
|
Valine | 1 | 2012 | 176 | 0.020 |
Why?
|
Behavior, Animal | 1 | 1995 | 709 | 0.020 |
Why?
|
Lentivirus | 1 | 2012 | 169 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2012 | 549 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2012 | 303 | 0.020 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2014 | 589 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2013 | 1082 | 0.020 |
Why?
|
Biological Availability | 1 | 2011 | 214 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2013 | 7222 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2008 | 4233 | 0.020 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2011 | 323 | 0.020 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2011 | 190 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2012 | 392 | 0.020 |
Why?
|
DNA-Binding Proteins | 3 | 2014 | 4821 | 0.020 |
Why?
|
Analysis of Variance | 1 | 1995 | 2307 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2012 | 591 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2003 | 1008 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2003 | 624 | 0.020 |
Why?
|
Carcinogens | 1 | 2011 | 384 | 0.020 |
Why?
|
3-Phosphoinositide-Dependent Protein Kinases | 1 | 2010 | 41 | 0.020 |
Why?
|
Immunoblotting | 1 | 2012 | 886 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2013 | 1519 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 1062 | 0.020 |
Why?
|
Glycine | 1 | 2012 | 289 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2008 | 6089 | 0.020 |
Why?
|
Acute Disease | 1 | 1995 | 2422 | 0.020 |
Why?
|
Proteolysis | 1 | 2011 | 370 | 0.020 |
Why?
|
Halogenation | 1 | 2009 | 14 | 0.020 |
Why?
|
Poly A | 1 | 2009 | 87 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2012 | 368 | 0.020 |
Why?
|
Cyclooxygenase 2 | 1 | 2011 | 483 | 0.020 |
Why?
|
Surface Plasmon Resonance | 1 | 2009 | 105 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2012 | 11538 | 0.020 |
Why?
|
Hydrolysis | 1 | 2009 | 227 | 0.020 |
Why?
|
Genes, p53 | 1 | 2013 | 1090 | 0.020 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2012 | 665 | 0.020 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2010 | 280 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2014 | 1152 | 0.020 |
Why?
|
HT29 Cells | 1 | 2008 | 159 | 0.020 |
Why?
|
Stem Cells | 2 | 2005 | 1213 | 0.020 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2008 | 132 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2010 | 6942 | 0.020 |
Why?
|
Female | 4 | 2013 | 141928 | 0.020 |
Why?
|
Gastrointestinal Tract | 1 | 2011 | 324 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2011 | 1764 | 0.020 |
Why?
|
Cattle | 1 | 2009 | 783 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2009 | 401 | 0.020 |
Why?
|
Carcinogenesis | 1 | 2014 | 1026 | 0.020 |
Why?
|
DNA Primers | 1 | 2009 | 1399 | 0.020 |
Why?
|
Administration, Oral | 1 | 2011 | 1544 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2009 | 663 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 3203 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2011 | 1620 | 0.020 |
Why?
|
Flight, Animal | 1 | 2005 | 12 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2011 | 1538 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2012 | 5159 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2012 | 3033 | 0.020 |
Why?
|
Tongue | 1 | 2005 | 77 | 0.020 |
Why?
|
GATA4 Transcription Factor | 1 | 2005 | 45 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2005 | 252 | 0.020 |
Why?
|
Cell Survival | 1 | 2011 | 3045 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 1489 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2012 | 1546 | 0.020 |
Why?
|
Monosaccharides | 1 | 2004 | 24 | 0.020 |
Why?
|
Ions | 1 | 2004 | 53 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2005 | 448 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2011 | 1547 | 0.020 |
Why?
|
Protein Structure, Quaternary | 1 | 2004 | 138 | 0.020 |
Why?
|
Apoptosis | 2 | 2011 | 7591 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2011 | 3101 | 0.020 |
Why?
|
Oligosaccharides | 1 | 2004 | 110 | 0.020 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2005 | 268 | 0.010 |
Why?
|
Animals, Genetically Modified | 1 | 2005 | 406 | 0.010 |
Why?
|
Organ Specificity | 1 | 2005 | 699 | 0.010 |
Why?
|
Vitamins | 1 | 2004 | 157 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 2594 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2011 | 3981 | 0.010 |
Why?
|
Phosphorylation | 1 | 2011 | 4804 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 4938 | 0.010 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2005 | 287 | 0.010 |
Why?
|
Heart Atria | 1 | 2005 | 352 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2010 | 5395 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2005 | 769 | 0.010 |
Why?
|
Cell Lineage | 1 | 2005 | 668 | 0.010 |
Why?
|
Oligopeptides | 1 | 2004 | 429 | 0.010 |
Why?
|
GATA5 Transcription Factor | 1 | 2001 | 4 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6207 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2008 | 1439 | 0.010 |
Why?
|
Culture Techniques | 1 | 2001 | 132 | 0.010 |
Why?
|
Endoderm | 1 | 2001 | 55 | 0.010 |
Why?
|
Motor Activity | 1 | 2005 | 693 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2010 | 3821 | 0.010 |
Why?
|
Chick Embryo | 1 | 2001 | 242 | 0.010 |
Why?
|
Amides | 1 | 2001 | 123 | 0.010 |
Why?
|
rho-Associated Kinases | 1 | 2001 | 85 | 0.010 |
Why?
|
Spleen | 1 | 2003 | 676 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2005 | 846 | 0.010 |
Why?
|
Cell Polarity | 1 | 2001 | 208 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2005 | 1555 | 0.010 |
Why?
|
Stomach | 1 | 2003 | 387 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2012 | 10001 | 0.010 |
Why?
|
Myocytes, Cardiac | 1 | 2005 | 764 | 0.010 |
Why?
|
Gastric Mucosa | 1 | 2003 | 613 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 7226 | 0.010 |
Why?
|
Trans-Activators | 1 | 2005 | 1555 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2005 | 1270 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2005 | 5637 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2001 | 1265 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2005 | 5710 | 0.010 |
Why?
|
Methylhistidines | 1 | 1994 | 10 | 0.010 |
Why?
|
Histamine Release | 1 | 1994 | 15 | 0.010 |
Why?
|
Receptors, Glutamate | 1 | 1994 | 19 | 0.010 |
Why?
|
Gliosis | 1 | 1994 | 41 | 0.010 |
Why?
|
Pyridines | 1 | 2001 | 1244 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2005 | 7548 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2005 | 3343 | 0.010 |
Why?
|
Necrosis | 1 | 1994 | 580 | 0.010 |
Why?
|
Neuroglia | 1 | 1994 | 223 | 0.010 |
Why?
|
Glutamine | 1 | 1994 | 299 | 0.010 |
Why?
|
Glutamic Acid | 1 | 1994 | 309 | 0.010 |
Why?
|
Cell Death | 1 | 1994 | 671 | 0.010 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 1994 | 259 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2012 | 32848 | 0.010 |
Why?
|